FI
CMTA

Fosun International’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Fosun International’s Portfolio CMTA Stock Details CMTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-244,826
Closed -$6.37M – 334
2019
Q1 		$6.37M Buy
244,826
+10,300
+4% +$192K 0.4% 37
2018
Q4 		$2.63M Buy
+234,526
New +$2.92M 0.16% 72

Fosun International's CMTA Position: Q2 2019 in Review

Fosun International sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 244,826 shares — an estimated $6.37M sold.

Fosun International first reported a position in CMTA in Q4 2018 and held it in 2 quarters. The position peaked at $6.37M in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

  • Fosun International reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
  • Fosun International sold 244,826 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $6.37M.
  • Fosun International first reported a position in Clementia Pharmaceuticals Inc. in Q4 2018 and held it in 2 quarters.
  • Fosun International's Clementia Pharmaceuticals Inc. position peaked at $6.37M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Fosun International's 13F filing for Q2 2019, filed 12 Aug 2019.